16-18793378-TA-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP6_Moderate
The NM_015161.3(ARL6IP1):c.494-9del variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000143 in 1,480,106 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.000021 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00016 ( 0 hom. )
Consequence
ARL6IP1
NM_015161.3 splice_polypyrimidine_tract, intron
NM_015161.3 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.64
Genes affected
ARL6IP1 (HGNC:697): (ADP ribosylation factor like GTPase 6 interacting protein 1) This gene belongs to the ARL6ip family and encodes a transmembrane protein that is predominantly localized to intracytoplasmic membranes. It is highly expressed in early myeloid progenitor cells and thought to be involved in protein transport, membrane trafficking, or cell signaling during hematopoietic maturation. Mutations in this gene are associated with spastic paraplegia 61 (SPG61). Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant 16-18793378-TA-T is Benign according to our data. Variant chr16-18793378-TA-T is described in ClinVar as [Benign]. Clinvar id is 707178.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARL6IP1 | NM_015161.3 | c.494-9del | splice_polypyrimidine_tract_variant, intron_variant | ENST00000304414.12 | NP_055976.1 | |||
ARL6IP1 | NM_001313858.1 | c.407-9del | splice_polypyrimidine_tract_variant, intron_variant | NP_001300787.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARL6IP1 | ENST00000304414.12 | c.494-9del | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_015161.3 | ENSP00000306788 | P1 | |||
ARL6IP1 | ENST00000563861.5 | c.*76-9del | splice_polypyrimidine_tract_variant, intron_variant, NMD_transcript_variant | 1 | ENSP00000456596 | |||||
ARL6IP1 | ENST00000546206.6 | c.407-9del | splice_polypyrimidine_tract_variant, intron_variant | 2 | ENSP00000440048 | |||||
ARL6IP1 | ENST00000562819.5 | c.149-9del | splice_polypyrimidine_tract_variant, intron_variant | 5 | ENSP00000457372 |
Frequencies
GnomAD3 genomes AF: 0.0000205 AC: 3AN: 146314Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
3
AN:
146314
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000157 AC: 209AN: 1333792Hom.: 0 Cov.: 21 AF XY: 0.000155 AC XY: 103AN XY: 666324
GnomAD4 exome
AF:
AC:
209
AN:
1333792
Hom.:
Cov.:
21
AF XY:
AC XY:
103
AN XY:
666324
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000205 AC: 3AN: 146314Hom.: 0 Cov.: 33 AF XY: 0.0000141 AC XY: 1AN XY: 71122
GnomAD4 genome
AF:
AC:
3
AN:
146314
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
71122
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hereditary spastic paraplegia 61 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 12, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at